Clinical Trial Update: Desensitization and Cross-Desensitization During Oral Grass or Ragweed Pollen Immunotherapy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating desensitization and cross-desensitization during oral grass or ragweed pollen immunotherapy has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunologic Desensitization

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Immunologic Desensitization | Phase 3 | Status: TERMINATED | Results posted: 2022-03-18